Event Info


Covid-19 Webcast

Fighting Global COVID-19 Together: Clinical Experience Sharing and Discussion

  • Date: 28/03/2020Time: 16:00 - 18:00 (China Standard Time)

Add To Calendar:

The ongoing COVID-19 outbreak has the potential to impact every healthcare system across the globe. While the situation in China appears to be reaching a turning point, the World Health Organization (WHO) recently characterizes COVID-19 as a pandemic at the global level. Till Mar 18th, 191,127 confirmed, 7,807 deaths, 135 countries/territories/areas reported* globally. Europe has now become the epicenter of the pandemic, with more reported cases and deaths than the rest of the world combined, apart from China. The world must unite together and spare no effort to contain the virus. During this webcast, leading Chinese experts on COVID-19 and top global experts will share and discuss the latest scientific insights regarding COVID-19 disease development, as well as clinical experience in treating COVID-19 patients.
By continuing to use this website, you consent to the terms of Webstream Communication's Privacy Policy and the Privacy Notice
This webcast has been initiated, organised and funded by AstraZeneca. The content is intended for HealthCare Professionals for medical educational purposes only. Expert opinion of the participating physicians are based on their experience to date managing COVID-19 in their home countries. Some therapies and product classes may not be available in your country. AstraZeneca is not responsible for, and may not necessarily agree with the views and opinions expressed by the participating physicians, and does not recommend any treatment or course of action. Please note the date and time of the webcast recording and seek local governmental advice for latest advice on diagnosis and treatment
Approval Code: Z2-0752 Expiration date June 27, 2020

This webcast will be broadcast in English and simultaneously translated in the following languages. Please choose a broadcast language to continue

Add To Calendar:

We use cookies to improve your browsing experience. You consent to our cookies policy if you continue to use this website.